Sign In
Last checked at 27 Dec 2006 14:53
Immupharma PLC27 December 2006 ImmuPharma PLC (the "Company") Voting Rights and Capital 27 December 2006 In conformity with the Transparency Directive's transitional provision 6, theCompany notifies the market of the following: The Company's issued share capital consists of 72,488,149 Ordinary Shares of 10peach which entitle the holder to one vote per share. Therefore, the total number of voting rights is 72,488,149. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, the Company under the FSA'sDisclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Immupharma Regulatory News (IMM)
IMM Share
Price
IMM Share
News
IMM Share
Chat
IMM Share
Trades2
IMM
Live RNS
IMM Share
Charts
IMM Level 2
Console
IMM Live
Share Price
IMM Broker
Ratings
IMM Directors
Deals
IMM Financial
Diary
IMM
Fundamentals
IMM Short
Positions
IMM
Media
IMM Company
Research
IMM Company
Timeline
Immupharma Information
Share Price Information for Immupharma (IMM)
Share Price is delayed by 15 minutes
Get Live Data
4.045
0.00 (0.00%)
Bid:
3.60
Ask:
4.295
Spread:
0.695 (19.306%)
Market Cap:
£25.24m
Last checked at -
Intraday Immupharma Share Chart
Total Voting Rights
| Date | Source | Headline | |
|---|---|---|---|
| 10th Jul 2007 | 7:01 am | RNS | Pivotal phase II/III trial |
| 13th Jun 2007 | 2:00 pm | RNS | AGM and Board Update |
| 1st May 2007 | 7:02 am | RNS | Preliminary Results |
| 27th Apr 2007 | 4:02 pm | RNS | Board Appointment |
| 15th Feb 2007 | 7:01 am | RNS | Appointment of adviser |
| 7th Feb 2007 | 7:01 am | RNS | Board Changes |
| 19th Jan 2007 | 8:57 am | RNS | Total Voting Rights |
| 5th Jan 2007 | 2:27 pm | RNS | Issue of Equity |
| 27th Dec 2006 | 2:53 pm | RNS | Total Voting Rights |
| 21st Dec 2006 | 7:01 am | RNS | Issue of Equity |
| 30th Oct 2006 | 7:01 am | RNS | Further Phase II Data |
| 17th Oct 2006 | 7:00 am | RNS | Phase II Data |
| 2nd Oct 2006 | 7:01 am | RNS | FDA Meeting on Lupus |
| 26th Sep 2006 | 7:01 am | RNS | Interim Results |
| 1st Aug 2006 | 7:01 am | RNS | Preliminary Results |
| 5th Jul 2006 | 7:00 am | RNS | Start of phase II trial |
| 12th Jun 2006 | 5:04 pm | RNS | Accounting reference dates |
| 10th May 2006 | 7:00 am | RNS | Phase 1 Lupus results |
| 11th Apr 2006 | 7:00 am | RNS | Research Grants |
| 15th Feb 2006 | 1:56 pm | RNS | Result of EGM and Placing |
| 24th Jan 2006 | 4:30 pm | RNS | Sch 1 Update - ImmuPharma plc |
| 23rd Jan 2006 | 4:27 pm | RNS | Circ re. ImmuPharma posted |
| 30th Nov 2005 | 1:38 pm | RNS | Interim Results |
| 27th May 2005 | 1:29 pm | RNS | Final Results |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.
Follow the stocks
